List of insiders holdings for Chemomab Therapeutics Ltd.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | THIEL PETER 10% Owner |
2021-03-26 08:10:07 | 22,631,260 0 |
22,631,260 | Form 13G |
| 2 | Access Industries Holdings LLC Clal Biotechnology Industries Ltd. ACCESS INDUSTRIES LLC ACCESS INDUSTRIES MANAGEMENT LLC Blavatnik Len 10% Owner |
2021-04-15 17:28:03 | 5,057,766 0 |
5,057,766 | Form 13D |
| 3 | Gabriel Capital Management Ltd. 10% Owner |
2022-02-10 16:02:58 | 3,087,040 0 |
3,087,040 | Form 13G |
| 4 | Haluska Frank Chief Executive Officer |
2020-01-02 16:33:58 | 2,148,236 0 |
2,148,236 | Form 3 |
| 5 | OrbiMed Israel GP Ltd. OrbiMed Israel BioFund GP Limited Partnership 10% Owner |
2024-09-16 16:34:03 | 1,860,906 0 |
1,860,906 | Form 13D |
| 6 | Mor George Adi Chief Scientific Officer |
2024-11-29 15:04:59 | 898,221 0 |
898,221 | Form 13D |
| 7 | Pfost Dale R Chief Executive Officer |
2022-03-15 16:10:10 | 461,853 0 |
461,853 | Form 4 |
| 8 | VERU DENNISON T Director |
2020-01-02 16:34:21 | 81,900 369,640 |
451,540 | Form 3 |
| 9 | Burgin Jonathan See Remarks |
2020-01-02 16:34:45 | 340,037 0 |
340,037 | Form 3 |
| 10 | Kerstein David Chief Medical Officer |
2020-01-02 16:31:04 | 340,000 0 |
340,000 | Form 3 |
| 11 | Fatal Sigal Chief Financial Officer |
2023-06-16 16:03:05 | 273,669 0 |
273,669 | Form 4 |
| 12 | Knickerbocker Ron See Remarks |
2020-01-02 16:32:13 | 235,000 0 |
235,000 | Form 3 |
| 13 | Marvin Donald Executive VP, CFO & COO |
2022-06-21 06:01:38 | 198,875 0 |
198,875 | Form 4 |
| 14 | SQUINTO STEPHEN P Director |
2021-04-21 17:16:57 | 168,624 0 |
168,624 | Form 4 |
| 15 | Frankel Matthew Bejosa Chief Medical Officer |
2022-11-15 16:03:38 | 125,000 0 |
125,000 | Form 3 |
| 16 | Gilon Ohev-Zion Michal VP, Research and Development |
2020-01-02 16:33:35 | 100,254 0 |
100,254 | Form 3 |
| 17 | Daly Sean T VP, Clinical Operations |
2020-01-02 16:32:44 | 80,000 0 |
80,000 | Form 3 |
| 18 | Aharon Arnon Chief Medical Officer |
2021-03-25 10:11:21 | 75,232 0 |
75,232 | Form 3 |
| 19 | HOWARD LAWRENCE Director |
2020-01-02 16:30:40 | 55,000 15,385 |
70,385 | Form 3 |
| 20 | Darvish Nissim Director |
2023-07-05 17:48:43 | 57,456 0 |
57,456 | Form 4 |
| 21 | Alon Ruth Director |
2020-01-02 16:35:08 | 55,353 0 |
55,353 | Form 3 |
| 22 | Makov Efrat Director |
2020-01-02 16:31:25 | 55,353 0 |
55,353 | Form 3 |
| 23 | Polovets Stanislav Director |
2021-03-12 16:28:05 | 55,000 0 |
55,000 | Form 4 |
| 24 | HARDY REGINALD L Director |
2020-01-02 16:35:30 | 55,000 0 |
55,000 | Form 3 |
| 25 | Kohlberg Isaac T. Director |
2020-01-02 16:31:51 | 55,000 0 |
55,000 | Form 3 |
| 26 | Cohen Neil Harris Director |
2023-03-23 07:35:31 | 36,267 0 |
36,267 | Form 4 |
| 27 | Quigley Jill M. Director |
2023-06-20 06:03:03 | 34,137 0 |
34,137 | Form 4 |
| 28 | Roshan Salar Head of Business Development |
2020-01-02 16:33:06 | 30,000 0 |
30,000 | Form 3 |
| 29 | Nicaise Claude Director |
2023-03-23 07:36:58 | 25,561 0 |
25,561 | Form 4 |
| 30 | Moses Alan Charles Director |
2023-03-23 07:38:42 | 25,561 0 |
25,561 | Form 4 |
| 31 | Maryles Joel Michael Director |
2022-05-25 16:03:50 | 20,137 0 |
20,137 | Form 4 |
| 32 | Fine Andrew Chief Financial Officer |
2021-03-11 18:34:09 | 0 0 |
0 | Form 3 |
| 33 | DiPalma Stephen J. Chief Financial Officer |
2020-05-07 16:16:21 | 0 0 |
0 | Form 3 |
| 34 | Gonen Ofer Director |
2020-01-02 17:08:41 | 0 0 |
0 | Form 3 |